High expression of FOXO3 has a favorable prognosis in acute myeloid leukemia 289, breast cancer 290, bladder cancer 291, gastric cancer 292, nasopharyngeal carcinoma 293 and human ovarian cancer 294. Here, FOXO3 is linked to breast carcinoma.